pharmaphorum

OCTOBER 21, 2021

Analysts were predicting sales of Biogen’s recently approved Alzheimer’s therapy Aduhelm may start to gather a little momentum in the third quarter, but the drug seems to be going into reverse. Vounatsos also insisted that Aduhelm’s price tag has not been a factor discouraging treatment with the drug.

Sales 120

Sales Doctors Doctor Gene Therapy 120

XTalks

AUGUST 23, 2021

With this in mind, here are six considerations for Alzheimer’s clinical trials going forward and how some of the experts at AAIC 2021 plan to tackle these challenges. Are Placebo Arms Still Ethical in Alzheimer’s Clinical Trials? Managing Patient Attrition in Ongoing Alzheimer’s Clinical Trials.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52

pharmaphorum

FEBRUARY 26, 2021

Today, Janssen is one of the world’s leading research-based pharma companies and markets prescription medicines in the areas of gastroenterology, women’s health, mental health, neurology and HIV/AIDS, to name a few. “Dr For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags.

Sales 125

Sales Production Pharma Companies Marketing 125